Related Experiment Video
Updated: Mar 5, 2026

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline
Rokusuke Yoshikawa1, Junko S Takeuchi1, Eri Yamada1
1Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan.
Abstract:
The interplay between viral and host proteins has been well studied to elucidate virus-host interactions and their relevance to virulence. Mammalian genes encode apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins, which act as intrinsic restriction factors against lentiviruses. To overcome APOBEC3-mediated antiviral actions, lentiviruses have evolutionarily acquired an accessory protein, viral infectivity factor (Vif), and Vif degrades host APOBEC3 proteins via a ubiquitin/proteasome-dependent pathway. Although the Vif-APOBEC3 interaction and its evolutionary significance, particularly those of primate lentiviruses (including HIV) and primates (including humans), have been well investigated, those of nonprimate lentiviruses and nonprimates are poorly understood. Moreover, the factors that determine lentiviral pathogenicity remain unclear. Here, we focus on feline immunodeficiency virus (FIV), a pathogenic lentivirus in domestic cats, and the interaction between FIV Vif and feline APOBEC3 in terms of viral virulence and evolution. We reveal the significantly reduced diversity of FIV subtype B compared to that of other subtypes, which may associate with the low pathogenicity of this subtype. We also demonstrate that FIV subtype B Vif is less active with regard to feline APOBEC3 degradation. More intriguingly, we further reveal that FIV protease cleaves feline APOBEC3 in released virions. Taken together, our findings provide evidence that a lentivirus encodes two types of anti-APOBEC3 factors, Vif and viral protease.IMPORTANCE During the history of mammalian evolution, mammals coevolved with retroviruses, including lentiviruses. All pathogenic lentiviruses, excluding equine infectious anemia virus, have acquired the vif gene via evolution to combat APOBEC3 proteins, which are intrinsic restriction factors against exogenous lentiviruses. Here we demonstrate that FIV, a pathogenic lentivirus in domestic cats, antagonizes feline APOBEC3 proteins by both Vif and a viral protease. Furthermore, the Vif proteins of an FIV subtype (subtype B) have attenuated their anti-APOBEC3 activity through evolution. Our findings can be a clue to elucidate the complicated evolutionary processes by which lentiviruses adapt to mammals.
Insights
Feline immunodeficiency virus (FIV) uses both Vif protein and protease to counteract host APOBEC3 restriction. FIV subtype B shows reduced Vif activity, potentially explaining its lower pathogenicity.
Area of Science:
- Virology
- Molecular Biology
- Evolutionary Biology
Background:
- Mammalian apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins restrict lentiviruses.
- Lentiviruses, like human immunodeficiency virus (HIV), evolved viral infectivity factor (Vif) to degrade APOBEC3 proteins.
- Interactions between primate lentiviruses and APOBEC3 are well-studied, but nonprimate lentivirus interactions are less understood.
Purpose of the Study:
- Investigate the interaction between feline immunodeficiency virus (FIV) Vif and feline APOBEC3.
- Elucidate the roles of FIV Vif and protease in viral virulence and evolution.
- Understand the factors influencing lentiviral pathogenicity in nonprimate hosts.
Main Methods:
- Comparative analysis of FIV subtype diversity and pathogenicity.
- Biochemical assays to assess FIV Vif activity against feline APOBEC3.
- Investigation of FIV protease activity on feline APOBEC3 in released virions.
Main Results:
- FIV subtype B exhibits significantly reduced genetic diversity and lower pathogenicity compared to other subtypes.
- FIV subtype B Vif shows attenuated feline APOBEC3 degradation activity.
- FIV protease was found to cleave feline APOBEC3 in released virions.
Conclusions:
- Feline immunodeficiency virus employs a dual strategy against feline APOBEC3, utilizing both Vif and viral protease.
- Evolutionary attenuation of Vif activity in FIV subtype B correlates with its reduced pathogenicity.
- These findings reveal novel mechanisms of lentiviral adaptation and co-evolution with mammalian hosts.
Related Concept Videos
Leaky Scanning
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Mutations
Retroviruses
Retrovirus Life Cycles

